ALB and lymphoma: A retrospective study of 807 patients with acute or lymphoma ATL diagnosed between 2000 and 2009 at 81 institutions across Japan identified clinical stage, performance status, age, albumin, and soluble interleukin 2 receptor (sIL-2R) as prognostic factors.